New therapies requiring ultra large scale monoclonal Ab production in microalgae [ 1/1/2021 - 12/31/2023 ]

Research Grant

Brief description Monoclonal antibodies target pathogens and molecules with exquisite specificity, and are essential for therapeutics and diagnostics. They are currently made using high-tech/limited-capacity mammalian cell cultures which limit them to low-dose applications. We aim to enable new, high-dose antibody therapies (e.g. antiviral treatments, passive immunisation) via rapid, low-cost, dramatically larger-scale production of valuable medicinal antibodies in a photosynthetic-driven, green algae system.

Funding Amount $630,089

Funding Scheme Ideas Grants

Chief Investigator Prof Ben Hankamer

Notes Ideas Grants